FTC Expands Scope of Hart-Scott-Rodino Rules for Pharmaceutical Licenses

Summary: The Federal Trade Commission adopted new rules that will expand the number of pharmaceutical licensing transactions that are subject to Hart-Scott-Rodino filings and review by the FTC or Department of Justice. The new rules apply to licenses involving the transfer of exclusive rights to a pharmaceutical patent or part of patent.